Dr Nissen discusses the impetus behind the study, the potential public health implications of the results, and more.
Sydney Jennings
Advertisement
Sydney Jennings is the editor of Patient Care Online. She joined MJH Life Sciences in March 2018 after graduating from the University of Connecticut with a BA in Journalism. She can be reached at [email protected].
Articles by Sydney Jennings
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Adults receiving semaglutide for the first time achieved weight loss of 14.3% at 12 months vs 10.6% among those who had previously taken a different antiobesity drug.
Your daily dose of the clinical news you may have missed.
Poor cardiovascular health at midlife was associated with a decline in the mental processing speed of Black women, but not White women, according to a new study.
Your daily dose of the clinical news you may have missed.
Patients with AF aged younger than 65 years have substantial comorbidity burden that may impact their future risk of mortality, reported researchers.
Your daily dose of the clinical news you may have missed.
Researchers found that the COVID-19 booster dose elicited a 71%-84% increase in the median anti-spike half-life over that of the primary series.
Your daily dose of the clinical news you may have missed.
Women with new-onset HTN faced a 45% greater risk of newly self-reported fibroids and those with untreated HTN had a 19% greater risk, according to a new study.
Your daily dose of the clinical news you may have missed.
Vaccine efficacy remained high at 82% at year 11 following vaccination, according to new long-term data.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
With the rise in demand for newer antiobesity medications, clinicians may face more questions from patients. Here, a primer on the drawbacks and benefits to keep in mind.
Nearly one-quarter of hospitalized adults aged 50 years and older with RSV experienced an acute cardiac event, according to results of a new study.
Your daily dose of the clinical news you may have missed.
Results of a recent study support the importance of lifestyle interventions to reduce the burden of breathlessness in middle-aged adults.
Semaglutide Improves Functional Status, Body Weight in Patients with HFpEF, Obesity, T2D: Daily Dose
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
The additional indication for benralizumab was supported by data from the phase 3 TATE trial.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
ACC.24: Adults with a history of CVD consumed more than double the recommended daily sodium amount, reported researchers.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
The end of another quarter means a new list of FDA-approved drugs for conditions treated in primary care. Are you up-to-date? Click through to find out.
The program, when implemented with support of resident training and tangible tools, reduced parent-reported injuries throughout the first 2 years of life.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Newer GLP-1 Therapies Linked to Fewer Alcohol-Related Hospitalizations in Adults With AUD
2
Compulsive Smartphone Use Linked to Depressive Symptoms in Older Adults
3
2026 Dyslipidemia Guideline Expands Statin Eligibility to 21.5 Million More US Adults
4
Early Liver Disease Detection Starts in Primary Care: A Q&A With Stevan Gonzalez, MD
5